Cargando…
Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids
The early and accurate prediction of the hepatotoxicity of new drug targets during nonclinical drug development is important to avoid postmarketing drug withdrawals and late-stage failures. We previously established long-term expandable and functional human-induced pluripotent stem cell (iPSC)-deriv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827634/ https://www.ncbi.nlm.nih.gov/pubmed/33440728 http://dx.doi.org/10.3390/cells10010126 |
_version_ | 1783640811294949376 |
---|---|
author | Mun, Seon Ju Lee, Jaeseo Chung, Kyung-Sook Son, Mi-Young Son, Myung Jin |
author_facet | Mun, Seon Ju Lee, Jaeseo Chung, Kyung-Sook Son, Mi-Young Son, Myung Jin |
author_sort | Mun, Seon Ju |
collection | PubMed |
description | The early and accurate prediction of the hepatotoxicity of new drug targets during nonclinical drug development is important to avoid postmarketing drug withdrawals and late-stage failures. We previously established long-term expandable and functional human-induced pluripotent stem cell (iPSC)-derived liver organoids as an alternative source for primary human hepatocytes. However, PSC-derived organoids are known to present immature fetal characteristics. Here, we treated these liver organoids with microbial short-chain fatty acids (SCFAs) to improve metabolic maturation based on microenvironmental changes in the liver during postnatal development. The effects of the three main SCFA components (acetate, propionate, and butyrate) and their mixture on liver organoids were determined. Propionate (1 µM) significantly promoted the CYP3A4/CYP3A7 expression ratio, and acetate (1 µM), propionate (1 µM), and butyrate (1 µM) combination treatment, compared to no treatment (control), substantially increased CYP3A4 activity and albumin secretion, as well as gene expression. More importantly, mixed SCFA treatment accurately revealed troglitazone-induced hepatotoxicity, which was redeemed on a potent CYP3A4 inhibitor ketoconazole treatment. Overall, we determined, for the first time, that SCFA mixture treatment might contribute to the accurate evaluation of the CYP3A4-dependent drug toxicity by improving metabolic activation, including CYP3A4 expression, of liver organoids. |
format | Online Article Text |
id | pubmed-7827634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78276342021-01-25 Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids Mun, Seon Ju Lee, Jaeseo Chung, Kyung-Sook Son, Mi-Young Son, Myung Jin Cells Article The early and accurate prediction of the hepatotoxicity of new drug targets during nonclinical drug development is important to avoid postmarketing drug withdrawals and late-stage failures. We previously established long-term expandable and functional human-induced pluripotent stem cell (iPSC)-derived liver organoids as an alternative source for primary human hepatocytes. However, PSC-derived organoids are known to present immature fetal characteristics. Here, we treated these liver organoids with microbial short-chain fatty acids (SCFAs) to improve metabolic maturation based on microenvironmental changes in the liver during postnatal development. The effects of the three main SCFA components (acetate, propionate, and butyrate) and their mixture on liver organoids were determined. Propionate (1 µM) significantly promoted the CYP3A4/CYP3A7 expression ratio, and acetate (1 µM), propionate (1 µM), and butyrate (1 µM) combination treatment, compared to no treatment (control), substantially increased CYP3A4 activity and albumin secretion, as well as gene expression. More importantly, mixed SCFA treatment accurately revealed troglitazone-induced hepatotoxicity, which was redeemed on a potent CYP3A4 inhibitor ketoconazole treatment. Overall, we determined, for the first time, that SCFA mixture treatment might contribute to the accurate evaluation of the CYP3A4-dependent drug toxicity by improving metabolic activation, including CYP3A4 expression, of liver organoids. MDPI 2021-01-11 /pmc/articles/PMC7827634/ /pubmed/33440728 http://dx.doi.org/10.3390/cells10010126 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mun, Seon Ju Lee, Jaeseo Chung, Kyung-Sook Son, Mi-Young Son, Myung Jin Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title | Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title_full | Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title_fullStr | Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title_full_unstemmed | Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title_short | Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids |
title_sort | effect of microbial short-chain fatty acids on cyp3a4-mediated metabolic activation of human pluripotent stem cell-derived liver organoids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827634/ https://www.ncbi.nlm.nih.gov/pubmed/33440728 http://dx.doi.org/10.3390/cells10010126 |
work_keys_str_mv | AT munseonju effectofmicrobialshortchainfattyacidsoncyp3a4mediatedmetabolicactivationofhumanpluripotentstemcellderivedliverorganoids AT leejaeseo effectofmicrobialshortchainfattyacidsoncyp3a4mediatedmetabolicactivationofhumanpluripotentstemcellderivedliverorganoids AT chungkyungsook effectofmicrobialshortchainfattyacidsoncyp3a4mediatedmetabolicactivationofhumanpluripotentstemcellderivedliverorganoids AT sonmiyoung effectofmicrobialshortchainfattyacidsoncyp3a4mediatedmetabolicactivationofhumanpluripotentstemcellderivedliverorganoids AT sonmyungjin effectofmicrobialshortchainfattyacidsoncyp3a4mediatedmetabolicactivationofhumanpluripotentstemcellderivedliverorganoids |